149 related articles for article (PubMed ID: 27424321)
1. Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin.
Drozd E; Krzysztoń-Russjan J; Marczewska J; Drozd J; Bubko I; Bielak M; Lubelska K; Wiktorska K; Chilmonczyk Z; Anuszewska E; Gruber-Bzura B
Biomed Pharmacother; 2016 Oct; 83():397-406. PubMed ID: 27424321
[TBL] [Abstract][Full Text] [Related]
2. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.
van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K
Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577
[TBL] [Abstract][Full Text] [Related]
3. Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance.
Drozd E; Gruber B; Marczewska J; Drozd J; Anuszewska E
Postepy Hig Med Dosw (Online); 2016 Apr; 70():319-28. PubMed ID: 27117108
[TBL] [Abstract][Full Text] [Related]
4. Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.
Deng J; Coy D; Zhang W; Sunkara M; Morris AJ; Wang C; Chaiswing L; St Clair D; Vore M; Jungsuwadee P
J Pharmacol Exp Ther; 2015 Nov; 355(2):272-9. PubMed ID: 26354996
[TBL] [Abstract][Full Text] [Related]
5. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
Akan I; Akan S; Akca H; Savas B; Ozben T
Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
[TBL] [Abstract][Full Text] [Related]
8. Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate.
Szwed M; Kania KD; Jozwiak Z
Biochimie; 2014 Dec; 107 Pt B():358-66. PubMed ID: 25312849
[TBL] [Abstract][Full Text] [Related]
9. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
[TBL] [Abstract][Full Text] [Related]
10. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype.
Schisselbauer JC; Crescimanno M; D'Alessandro N; Clapper M; Toulmond S; Tapiero H; Tew KD
Cancer Commun; 1989; 1(2):133-9. PubMed ID: 2639724
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.
Priebe W; Krawczyk M; Kuo MT; Yamane Y; Savaraj N; Ishikawa T
Biochem Biophys Res Commun; 1998 Jun; 247(3):859-63. PubMed ID: 9647783
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.
Crescimanno M; D'Alessandro N; Armata MG; Toulmond S; Tapiero H
Anticancer Res; 1991; 11(2):901-3. PubMed ID: 2064348
[TBL] [Abstract][Full Text] [Related]
13. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
Zhang W; Deng J; Sunkara M; Morris AJ; Wang C; St Clair D; Vore M
J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995
[TBL] [Abstract][Full Text] [Related]
14. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
Rocha Gda G; Oliveira RR; Kaplan MA; Gattass CR
Eur J Pharmacol; 2014 Oct; 741():140-9. PubMed ID: 25111243
[TBL] [Abstract][Full Text] [Related]
15. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
16. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
17. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
18. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
[TBL] [Abstract][Full Text] [Related]
19. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Cunha-Oliveira T; Ferreira IL; Oliveira CR; Rego AC
Free Radic Biol Med; 2012 Nov; 53(10):1857-67. PubMed ID: 22982598
[TBL] [Abstract][Full Text] [Related]
20. Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.
Gruber BM; Bubko I; Krzyszton-Russjan J; Anuszewska EL
Med Sci Monit; 2010 Jan; 16(1):BR45-51. PubMed ID: 20037485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]